NYSE - Delayed Quote
USD
Elanco Animal Health Incorporated (ELAN)
24.50
+0.08
(+0.33%)
At close: September 4 at 4:02:48 PM EDT
24.20
-0.30
(-1.22%)
After hours: September 4 at 7:55:18 PM EDT
Trade ELAN on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for ELAN
- Previous Close
24.42 - Open
24.20 - Bid 24.31 x 70000
- Ask 24.32 x 50000
- Day's Range
24.01 - 24.71 - 52 Week Range
18.22 - 27.98 - Volume
3,718,004 - Avg. Volume
6,026,269 - Market Cap (intraday)
12.241B - Beta (5Y Monthly) 1.68
- PE Ratio (TTM)
-- - EPS (TTM)
-0.41 - Earnings Date (est.) Nov 5, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
31.21
Recent News
View More
Performance Overview
Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
ELAN
8.26%
S&P 500 (^GSPC)
12.75%
1-Year Return
ELAN
40.24%
S&P 500 (^GSPC)
18.71%
3-Year Return
ELAN
97.74%
S&P 500 (^GSPC)
70.93%
5-Year Return
ELAN
28.26%
S&P 500 (^GSPC)
70.18%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 9/3/2026
-
Market Cap
12.20B
-
Enterprise Value
15.59B
-
Trailing P/E
--
-
Forward P/E
20.37
-
PEG Ratio (5yr expected)
4.04
-
Price/Sales (ttm)
2.43
-
Price/Book (mrq)
1.85
-
Enterprise Value/Revenue
3.11
-
Enterprise Value/EBITDA
20.11
Financial Highlights
Profitability and Income Statement
-
Profit Margin
-3.96%
-
Return on Assets (ttm)
1.56%
-
Return on Equity (ttm)
-2.98%
-
Revenue (ttm)
5.02B
-
Net Income Avi to Common (ttm)
-199M
-
Diluted EPS (ttm)
-0.41
Balance Sheet and Cash Flow
-
Total Cash (mrq)
530M
-
Total Debt/Equity (mrq)
64.25%
-
Levered Free Cash Flow (ttm)
826.88M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
24.50
+0.33%
Mkt Cap
12.241B
Industry
Drug Manufacturers—Specialty & Generic
38.25
-0.86%
Mkt Cap
1.553B
Industry
Drug Manufacturers—Specialty & Generic
6.56
-2.96%
Mkt Cap
2.453B
Industry
Drug Manufacturers—Specialty & Generic
34.94
+0.32%
Mkt Cap
4.124B
Industry
Drug Manufacturers—Specialty & Generic
14.09
-0.14%
Mkt Cap
2.449B
Industry
Drug Manufacturers—Specialty & Generic
155.64
-1.71%
Mkt Cap
15.821B
Industry
Drug Manufacturers—Specialty & Generic
18.45
-1.39%
Mkt Cap
58.92B
Industry
Drug Manufacturers—Specialty & Generic
4.4000
+1.15%
Mkt Cap
166.553M
Industry
Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View More-
Elanco Earnings: Continued Strength in Key New Products Supports Strong Quarter
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
RatingPrice Target -
Daily – Vickers Top Buyers & Sellers for 08/24/2026
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
-
Elanco Earnings: Continued Strength in Key New Products Supports Strong Quarter
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
RatingPrice Target -
Elanco Earnings: Continued Strength in Key New Products Supports Strong Quarter
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
RatingPrice Target
